Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1996
OBJECTIVES: I. Evaluate the safety and efficacy of synthetic dehydroepiandrosterone, GL701, in women with active systemic lupus erythematosus.
Epistemonikos ID: 3791242938615c8286101610f2d487556c9dda35
First added on: May 03, 2024